Sofinnova Investments’s Immunogen Inc IMGN Stock Holding History

Sofinnova Investments’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000,000	Closed	-$3.84M	–	64
2023 Q1	$3.84M	Buy	+1,000,000	New	+$4.26M	0.25%	42
2019 Q2	–	Sell	-150,000	Closed	-$406K	–	85
2019 Q1	$406K	Buy	+150,000	New	+$650K	0.04%	66

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sofinnova Investments's IMGN Position: Q1 2024 in Review

Sofinnova Investments sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,546,902 shares — an estimated $45.9M sold.

Sofinnova Investments first reported a position in IMGN in Q4 2018 and held it in 10 quarters. The position peaked at $45.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Sofinnova Investments reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Sofinnova Investments sold 1,546,902 Immunogen Inc shares in Q1 2024, an estimated $45.9M.
Sofinnova Investments first reported a position in Immunogen Inc in Q4 2018 and held it in 10 quarters.
Sofinnova Investments's Immunogen Inc position peaked at $45.9M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Sofinnova Investments's 13F filing for Q1 2024, filed 15 May 2024.